Federation des caisses Desjardins du Quebec’s Aerie Pharmaceuticals AERI Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,000	Closed	-$19.2K	–	2381
2019 Q3	$19.2K	Buy	+1,000	New	+$22.9K	﹤0.01%	1681
2018 Q2	–	Sell	-700	Closed	-$38K	–	2261
2018 Q1	$38K	Sell	700 -450	-39%	-$25.2K	﹤0.01%	1407
2017 Q4	$68.7K	Buy	+1,150	New	+$69.7K	﹤0.01%	1264

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's AERI Position: Q4 2019 in Review

Federation des caisses Desjardins du Quebec sold out of Aerie Pharmaceuticals (AERI) in Q4 2019, closing a stake of 1,000 shares — an estimated $19.2K sold.

Federation des caisses Desjardins du Quebec first reported a position in AERI in Q4 2017 and held it in 3 quarters. The position peaked at $68.7K in Q4 2017. 167 funds tracked by Wall St. Rank hold AERI as of Q4 2019.

Federation des caisses Desjardins du Quebec reported no remaining Aerie Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 1,000 Aerie Pharmaceuticals shares in Q4 2019, an estimated $19.2K.
Federation des caisses Desjardins du Quebec first reported a position in Aerie Pharmaceuticals in Q4 2017 and held it in 3 quarters.
Federation des caisses Desjardins du Quebec's Aerie Pharmaceuticals position peaked at $68.7K in Q4 2017.
167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2019.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2019, filed 30 Aug 2024.